| P50 | author | Wenrong Xu | Q88233159 |
| | Wei Zhu | Q89703419 |
| P2093 | author name string | Xu Zhang | |
| | Ruiwen Zhang | |
| | Hui Qian | |
| P2860 | cites work | Distinct antitumor properties of a type IV collagen domain derived from basement membrane | Q22253901 |
| | Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties | Q22254194 |
| | Cancer statistics, 2007 | Q29547293 |
| | Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors | Q29547596 |
| | Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos | Q30476162 |
| | Tumstatin, an endothelial cell-specific inhibitor of protein synthesis | Q34107979 |
| | Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model | Q34133208 |
| | Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases | Q34367266 |
| | Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins | Q35543014 |
| | Tumor necrosis factor, cancer and anticancer therapy. | Q36055874 |
| | Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy | Q36161416 |
| | Prostate cancer immunology: biology, therapeutics, and challenges | Q36309729 |
| | Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles | Q36901346 |
| | Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles | Q37090592 |
| | Stem and progenitor cell-mediated tumor selective gene therapy | Q37120161 |
| | Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model | Q37310677 |
| | Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma | Q38507328 |
| | Tumor vasculature-targeted delivery of tumor necrosis factor-alpha | Q39904196 |
| | A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs | Q39999044 |
| | Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy | Q40110233 |
| | Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs | Q40253468 |
| | Prostate cancer gene therapy-what have we learned and where are we going? | Q40286795 |
| | Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses | Q40302572 |
| | Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin | Q40817329 |
| | Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells | Q42829407 |
| | Approaches to utilize mesenchymal progenitor cells as cellular vehicles | Q44495575 |
| | Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells. | Q45870174 |
| | Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model | Q45875290 |
| | Construction, expression, and characterization of a new targeted bifunctional fusion protein: tumstatin45-132-TNF. | Q47586815 |
| | Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas | Q48926056 |
| | Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells. | Q50107871 |
| | Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors. | Q50737303 |
| | Multipotent adult progenitor cell isolation and culture procedures. | Q51117641 |
| | Human mesenchymal stem cells isolated from the umbilical cord. | Q53524682 |
| | Selective targeted delivery of TNFalpha to tumor blood vessels. | Q53855595 |
| | Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents | Q58828469 |
| | Gene therapy for prostate cancer | Q63977516 |
| | Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors | Q64378688 |
| | Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents | Q64379193 |
| | Human mesenchymal stem cells maintain transgene expression during expansion and differentiation | Q74024871 |
| | Clinical applications of TNF-alpha in cancer | Q77485569 |
| | Anti-tumor activity of mesenchymal stem cells producing IL-12 in a mouse melanoma model | Q79142180 |
| | Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells | Q80057941 |
| | Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells | Q81774923 |
| | Gene therapy for prostate cancer | Q94163813 |
| P433 | issue | 2 | |
| P921 | main subject | prostate cancer | Q181257 |
| | mesenchymal stem cell | Q1922379 |
| | TNF | Q18032037 |
| P304 | page(s) | 433-444 | |
| P577 | publication date | 2011-02-01 | |
| P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
| P1476 | title | Mesenchymal stem cells modified to express lentivirus TNF-α Tumstatin(45-132) inhibit the growth of prostate cancer | |
| P478 | volume | 15 | |